SE459783B - Stabilt plasminogenpreparat - Google Patents

Stabilt plasminogenpreparat

Info

Publication number
SE459783B
SE459783B SE8100393A SE8100393A SE459783B SE 459783 B SE459783 B SE 459783B SE 8100393 A SE8100393 A SE 8100393A SE 8100393 A SE8100393 A SE 8100393A SE 459783 B SE459783 B SE 459783B
Authority
SE
Sweden
Prior art keywords
plasminogen
preparation
stabilizer
soybean trypsin
aqueous solution
Prior art date
Application number
SE8100393A
Other languages
English (en)
Swedish (sv)
Other versions
SE8100393L (sv
Inventor
Y Uemura
K Uriyu
S Funakoshi
R Watanabe
M Ohgaki
Original Assignee
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP807280A external-priority patent/JPS56106594A/ja
Priority claimed from JP9134180A external-priority patent/JPS5716824A/ja
Application filed by Green Cross Corp filed Critical Green Cross Corp
Publication of SE8100393L publication Critical patent/SE8100393L/
Publication of SE459783B publication Critical patent/SE459783B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
SE8100393A 1980-01-25 1981-01-23 Stabilt plasminogenpreparat SE459783B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP807280A JPS56106594A (en) 1980-01-25 1980-01-25 Stabilizing method of plasminogen
JP9134180A JPS5716824A (en) 1980-07-03 1980-07-03 Plasminogen pharmaceutical and stabilizing method thereof

Publications (2)

Publication Number Publication Date
SE8100393L SE8100393L (sv) 1981-07-26
SE459783B true SE459783B (sv) 1989-08-07

Family

ID=26342511

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8100393A SE459783B (sv) 1980-01-25 1981-01-23 Stabilt plasminogenpreparat
SE8803798A SE8803798D0 (sv) 1980-01-25 1988-10-24 Plasminogenpreparat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8803798A SE8803798D0 (sv) 1980-01-25 1988-10-24 Plasminogenpreparat

Country Status (5)

Country Link
CH (1) CH650273A5 (xx)
DE (1) DE3102217A1 (xx)
FR (1) FR2474313A1 (xx)
GB (1) GB2068002B (xx)
SE (2) SE459783B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119157A1 (de) * 1981-05-14 1982-12-09 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von und danach hergestelltes plasminogen
EP0378208B2 (en) * 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066079A (en) * 1959-09-18 1962-11-27 American Cyanamid Co Methods for purifying plasminogen
US3865692A (en) * 1974-01-11 1975-02-11 Abbott Lab Method for making highly potent plasminogen
FR2347048A2 (fr) * 1976-04-07 1977-11-04 Choay Sa Compositions constituees par des composes du type plasminogene, notamment d'origine placentaire, procede d'obtention des ces compositions, et medicaments contenant ces compositions

Also Published As

Publication number Publication date
DE3102217C2 (xx) 1987-02-12
SE8803798L (sv) 1988-10-24
SE8803798D0 (sv) 1988-10-24
GB2068002B (en) 1983-06-29
FR2474313B1 (xx) 1984-02-10
CH650273A5 (de) 1985-07-15
DE3102217A1 (de) 1981-11-26
FR2474313A1 (fr) 1981-07-31
SE8100393L (sv) 1981-07-26
GB2068002A (en) 1981-08-05

Similar Documents

Publication Publication Date Title
Safer et al. Isolation of a 5-kilodalton actin-sequestering peptide from human blood platelets.
Cameron et al. Characterization of myotoxin a from the venom of prairie rattlesnake (Crotalus viridis viridis)
EP0124506B1 (de) Verfahren zur Inaktivierung von vermehrungsfähigen Krankheitserregern
Caprioli et al. A cell division-active protein from E. coli
DE3472894D1 (en) Methods for preparing protein compositions substantially free from infections agents
KR100186824B1 (ko) 알부민 제제 및 이의 제조방법
CA1163922A (en) Method for stabilizing plasminogen
Bailey et al. Further chemical studies on the tropomyosins of lamellibranch muscle with special reference to Pecten maximus
Heilbronn Purification of cholinesterase from horse serum
Lin et al. A comparison of lac repressor binding to operator and to nonoperator DNA
Nelson et al. The role of δ subunit in the coupling activity of chloroplast coupling factor 1
JPS6237010B2 (xx)
SE459783B (sv) Stabilt plasminogenpreparat
CA1337688C (en) Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
US8293242B2 (en) Ultra-high yield of alpha-1-anti-trypsin
Rüegg The proteins associated with contraction in lamellibranch ‘catch’muscle
Norrby Hemagglutination by measles virus II. Properties of the hemagglutinin and of the receptors on the erythrocytes
Miller Rivanol, resin and the isolation of thrombins
Paus α‐Mannosidase from Phaseolus vulgaris: Composition and Structural Properties
Oplatka et al. The contraction of “ghost” myofibrils and glycerinated muscle fibers irrigated with heavy meromyosin subfragment-l
JPH08506498A (ja) 非脂質被覆ウイルスの失活方法
Marin et al. Solubilization and purification of the ATPase from the tonoplast of Hevea
Kearney et al. The L-amino acid oxidases of snake venom. IV. The effect of anions on the reversible inactivation
EP0067293A2 (en) Method for isolating alpha-1-antitrypsin
EP0449897B1 (en) A pure factor i protein and a process for producing said protein

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8100393-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8100393-1

Format of ref document f/p: F